Literature DB >> 4035619

Relationship between saliva and free and total plasma theophylline concentrations in patients with chronic airflow obstruction.

P Ebden, D Leopold, D Buss, A P Smith, P A Routledge.   

Abstract

Total plasma and mixed stimulated saliva theophylline concentrations (by high performance liquid chromatography) and free plasma theophylline concentrations (by equilibrium dialysis) were measured in simultaneously collected samples from 32 outpatients receiving chronic oral theophylline treatment, who had received the drug at least two hours before sampling. There was a close relationship between saliva and total plasma theophylline concentration and between total saliva and free plasma concentration. The mean saliva to total plasma drug concentration ratio was 0.69 (SE 0.09) and the mean difference between paired saliva and free plasma concentration was 0.65 (0.17) microgram/ml. It is concluded that stimulated mixed saliva provides a simple, non-invasive method of assessing total (and free) plasma theophylline concentrations during chronic oral treatment. The therapeutic range for saliva, corresponding to the generally accepted total plasma concentration range (10-20 micrograms/ml), is approximately 7-14 micrograms/ml.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4035619      PMCID: PMC460125          DOI: 10.1136/thx.40.7.526

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  6 in total

Review 1.  Therapeutic drug monitoring in saliva.

Authors:  M Danhof; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

2.  The use of linear models and matrix least squares in clinical chemistry.

Authors:  S N Deming; S L Morgan
Journal:  Clin Chem       Date:  1979-06       Impact factor: 8.327

3.  Do saliva concentrations predict plasma unbound theophylline concentrations? A problem re-examined.

Authors:  C Knott; M Bateman; F Reynolds
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

4.  Theophylline analysis by reversed-phase high-pressure liquid chromatography: elimination of interferences.

Authors:  J R Miksic; B Hodes
Journal:  J Pharm Sci       Date:  1979-09       Impact factor: 3.534

5.  Unpredictability of theophylline saliva measurements in chronic obstructive pulmonary disease.

Authors:  L Hendeles; S Burkey; L Bighley; R Richardson
Journal:  J Allergy Clin Immunol       Date:  1977-12       Impact factor: 10.793

6.  Free and total plasma theophylline concentrations in chronic airflow obstruction.

Authors:  P Ebden; D Leopold; A P Smith; D Buss; P A Routledge
Journal:  Thorax       Date:  1984-05       Impact factor: 9.139

  6 in total
  4 in total

Review 1.  Therapeutic drug monitoring in saliva. An update.

Authors:  R K Drobitch; C K Svensson
Journal:  Clin Pharmacokinet       Date:  1992-11       Impact factor: 6.447

2.  Steady-state pharmacokinetics and effects of a new once-daily, slow-release theophylline capsule preparation in asthma.

Authors:  P E Williams; Y A Alwazir; P A Routledge; I A Campbell
Journal:  Br J Clin Pharmacol       Date:  1986-10       Impact factor: 4.335

3.  A descriptive systematic review of salivary therapeutic drug monitoring in neonates and infants.

Authors:  Laura Hutchinson; Marlene Sinclair; Bernadette Reid; Kathryn Burnett; Bridgeen Callan
Journal:  Br J Clin Pharmacol       Date:  2018-03-25       Impact factor: 4.335

4.  Variability of the serum protein binding of theophylline in patients with asthma and cystic fibrosis.

Authors:  J Blanchard; S Harvey; W J Morgan
Journal:  Br J Clin Pharmacol       Date:  1992-06       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.